(225)Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study

BACKGROUND: A remarkable therapeutic efficacy has been demonstrated with (225)Ac-prostate-specific membrane antigen (PSMA)-617 in heavily pre-treated metastatic castration-resistant prostate cancer (mCRPC) patients. We report our experience with (225)Ac-PSMA-617 therapy in chemotherapy-naïve patient...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Eur J Nucl Med Mol Imaging
Main Authors: Sathekge, Mike, Bruchertseifer, Frank, Knoesen, Otto, Reyneke, Florette, Lawal, Ismaheel, Lengana, Thabo, Davis, Cindy, Mahapane, Johncy, Corbett, Ceceila, Vorster, Mariza, Morgenstern, Alfred
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2018
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6267694/
https://ncbi.nlm.nih.gov/pubmed/30232539
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00259-018-4167-0
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados